Asset Management Corp’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Asset Management Corp’s Portfolio SEEL Stock Details SEEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$28K	Buy	+11	New	+$32.2K	0.02%	131
2022 Q4	–	Sell	-12	Closed	-$47K	–	167
2022 Q3	$47K	Buy	12 +6	+100%	+$23.6K	0.03%	154
2022 Q2	$16K	Buy	+6	New	+$15.6K	0.01%	157
2022 Q1	–	Sell	-3	Closed	-$16K	–	195
2021 Q4	$16K	Sell	3 -7	-70%	-$53.7K	0.01%	178
2021 Q3	$95K	Buy	10 +3	+43%	+$25.8K	0.05%	186
2021 Q2	$71K	Sell	7 -3	-30%	-$49.3K	0.04%	174
2021 Q1	$200	Sell	10 -11	-52%	-$128K	0.09%	178
2020 Q4	$130K	Buy	+21	New	+$82.4K	0.07%	163

Other funds holding SEEL

GJL

Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

MWM

Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Asset Management Corp's SEEL Position: Q1 2023 in Review

Asset Management Corp opened a new position in Seelos Therapeutics, Inc. Common Stock (SEEL) in Q1 2023: 11 shares worth $28K. The stake represents 0.02% of the portfolio and ranks #131 among its holdings. This is a return to the name: Asset Management Corp previously reported a position in SEEL as recently as Q3 2022.

Asset Management Corp first reported a position in SEEL in Q4 2020 and has held it in 8 quarters since. The position peaked at $130K in Q4 2020. 60 funds tracked by Wall St. Rank hold SEEL as of Q1 2023.

Asset Management Corp held 11 shares of Seelos Therapeutics, Inc. Common Stock worth $28K as of Q1 2023.
Seelos Therapeutics, Inc. Common Stock was a new Asset Management Corp position in Q1 2023.
Seelos Therapeutics, Inc. Common Stock made up 0.02% of Asset Management Corp's portfolio in Q1 2023, its #131 holding.
Asset Management Corp first reported a position in Seelos Therapeutics, Inc. Common Stock in Q4 2020 and has held it in 8 quarters since.
Asset Management Corp's Seelos Therapeutics, Inc. Common Stock position peaked at $130K in Q4 2020.
60 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Asset Management Corp's 13F filing for Q1 2023, filed 14 Apr 2023.